Alumis Inc. (ALMS)
ALMS trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$6.56
-7.08% on the day
Market cap
$849.1M
Small cap
Revenue · 2025
$24.1M
No prior year to compare
Net income · 2025
-$243.3M
-1011.7% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | ALMS on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2024 |
| SEC CIK | 0001847367 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $24.1M |
| Net income | -$243.3M |
| Operating income | -$453.8M |
| Net margin | -1011.7% |
| Operating margin | -1886.9% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $89.7M |
| Total assets | $411.9M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 35.3× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3ASR | 2026-03-19 |
| Latest annual report | 10-K | 2026-03-19 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report FORM 8-K | 8-K | 2026-09-01 |
| Latest proxy | DEFA14A | 2026-05-18 |
Source: SEC EDGAR submissions feed, 242 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -10.3% |
| 1 month | -27.7% |
| 3 months | -77.7% |
| Year to date | -37.8% |
| 1 year | +31.7% |
| From 52-week high | -80.0% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| JBIO | Jade Biosciences Inc. | $13.42 | -4.14% | $853.5M |
| CYRX | CryoPort Inc. | $16.95 | +0.65% | $858.5M |
| SPTX | Seaport Therapeutics Inc. | $16.08 | -6.24% | $860.8M |
| ANRO | Alto Neuroscience Inc. | $22.09 | -8.53% | $866.9M |
| KURA | Kura Oncology Inc. | $9.83 | -5.43% | $874.5M |
| RIGL | Rigel Pharmaceuticals Inc. | $47.14 | -3.42% | $880.6M |
| MLTX | MoonLake Immunotherapeutics | $10.41 | -2.53% | $886.0M |
| AVBP | ArriVent BioPharma Inc. | $16.09 | -2.25% | $793.4M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier